This analysis revealed that higher CERS4 mRNA expression levels were associated with poor overall survival in LumA breast cancer (TCGA-BRCA, P = 0.048; GSE96058, P = 0.0014; Fig. 1C). Here, CERS4 is linked to breast cancer.